Publicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (18)

2023

  1. Consensus Recommendations for Standardized Data Elements, Scales, and Time Segmentations in Studies of Human Circadian/Diurnal Biology and Stroke

    Stroke, Vol. 54, Núm. 7, pp. 1943-1949

  2. Safety and Efficacy of ApTOLL in Patients with Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial

    JAMA Neurology, Vol. 80, Núm. 8, pp. 779-788

  3. Use of Tenecteplase in Acute Ischemic Stroke in the Time of SARS-CoV-2

    Neurohospitalist, Vol. 13, Núm. 3, pp. 266-271

2022

  1. Insulin receptor activation by proinsulin preserves synapses and vision in retinitis pigmentosa

    Cell Death and Disease, Vol. 13, Núm. 4

2021

  1. Tlr2 gene deletion delays retinal degeneration in two genetically distinct mouse models of retinitis pigmentosa

    International Journal of Molecular Sciences, Vol. 22, Núm. 15

2020

  1. Programmed ‘disarming’ of the neutrophil proteome reduces the magnitude of inflammation

    Nature Immunology, Vol. 21, Núm. 2, pp. 135-144

2019

  1. Lack of the aryl hydrocarbon receptor accelerates aging in mice

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 33, Núm. 11, pp. 12644-12654

  2. Pharmacological Modulation of Neutrophil Extracellular Traps Reverses Thrombotic Stroke tPA (Tissue-Type Plasminogen Activator) Resistance

    Stroke, Vol. 50, Núm. 11, pp. 3228-3237

  3. Toll-like receptor 4 regulates subventricular zone proliferation and neuroblast migration after experimental stroke

    Brain, Behavior, and Immunity, Vol. 80, pp. 573-582

2018

  1. Features of aminopropyl modified mesoporous silica nanoparticles. Implications on the active targeting capability

    Materials Chemistry and Physics, Vol. 220, pp. 260-269

  2. Iron Overload Exacerbates the Risk of Hemorrhagic Transformation After tPA (Tissue-Type Plasminogen Activator) Administration in Thromboembolic Stroke Mice

    Stroke, Vol. 49, Núm. 9, pp. 2163-2172

  3. Myeloid cells as therapeutic targets in neuroinflammation after stroke: Specific roles of neutrophils and neutrophil–platelet interactions

    Journal of Cerebral Blood Flow and Metabolism, Vol. 38, Núm. 12, pp. 2150-2164

  4. TLR4-Binding DNA Aptamers Show a Protective Effect against Acute Stroke in Animal Models

    Molecular Therapy, Vol. 26, Núm. 8, pp. 2047-2059

2017

  1. Cytokines and Chemokines in Stroke

    Primer on Cerebrovascular Diseases: Second Edition (Elsevier Inc.), pp. 280-284

  2. Test repositioning for functional assessment of neurological outcome after experimental stroke in mice

    PLoS ONE, Vol. 12, Núm. 5

2016

  1. The kynurenine pathway in the acute and chronic phases of cerebral ischemia

    Current Pharmaceutical Design, Vol. 22, Núm. 8, pp. 1060-1073

2002

  1. Cerebrospinal fluid and plasma concentrations of nitric oxide metabolites are increased in dementia with Lewy bodies

    Neuroscience Letters, Vol. 333, Núm. 2, pp. 151-153

1999

  1. Nitric oxide synthase activity in human squamous cell carcinoma of the head and neck

    Laryngoscope, Vol. 109, Núm. 1, pp. 148-152